| Korea | Russia | Malaysia
Indonesia | All Others

eg.stem cell, stem cell treatment
Stem cell treatment | Parkinson's Disease | Multiple Sclerosis | ALS | Brain Injury | Spinal Cord Injury | Cerebaral Palsy | Batten Disease | Stroke
MSA | Muscular Dystrophy | Epilepsy | Optic neuritis | Encephalomyelitis | SMA | Huntingdon's disease | Friedrich ataxia | Diabetes
HOME > News > Article Content

New, Inexpensive Way to Predict Alzheimer's Disease


http://www.sciencedaily.com/releases/2010/04/100405111207.htm

ScienceDaily (Apr. 5, 2010)

Your brain's capacity for information is a reliable predictor of Alzheimer's disease and can be cheaply and easily tested, according to scientists.

"We have developed a low-cost behavioral assessment that can clue someone in to Alzheimer's disease at its earliest stage," said Michael Wenger, associate professor of psychology, Penn State. "By examining (information) processing capacity, we can detect changes in the progression of mild cognitive impairment (MCI)."

MCI is a condition that affects language, memory, and related mental functions. It is distinct from the ordinary mental degradation associated with aging and is a likely precursor to the more serious Alzheimer's disease. Both MCI and Alzheimer's are linked to a steady decline in the volume of the hippocampus, the area of the brain responsible for long term memory and spatial reasoning.

MRIs -- magnetic resonance imaging -- are the most reliable and direct way to detect hippocampal atrophy and diagnose MCI. But for many, the procedure is unavailable or too expensive.

"MRIs can cost hundreds of dollars an hour," Wenger said. "We created a much cheaper alternative, based on a memory test, that correlates with hippocampal degradation." Wenger and his collaborators at the Mayo Clinic College of Medicine, Rochester, Minn., detail their findings in a recent issue of the Journal of Mathematical Psychology.
From a computer model of an atrophying hippocampus, the researchers determined how to estimate capacity with a statistical measure of how quickly tasks are completed. Applying this analysis to a memory test for people with MCI, the researchers were able to gauge their hippocampal capacity and compare it to the progression of their ailment.
"My collaborators at the Mayo Clinic backed up this study with MRIs for the MCI group," Wenger said. "These capacity measures we developed showed a reliable relationship to the hippocampal volume measurements, so we know we are on the right track."
The scientists began by modeling the hippocampus as a complex electrical circuit. Equations governing electric current and voltage mimicked the electrical firing of neurons within the circuit. The researchers switched off neurons in the simulation to model atrophy of the hippocampus.

With fewer cells available to process electrical signals, the model hippocampus slowed down, but its capacity for processing information decreased at an even faster rate. Capacity was the most sensitive measure of how the hippocampus was deteriorating, more than the average processing speed.

"We then applied this to the gold standard of the field -- the Free and Cued Selective Reminding Test (FCSRT)," Wenger said. "This is a test that can discriminate between normal age-related memory changes and changes caused by impairment."

The researchers gave this test to five groups of participants: college students, healthy middle-aged adults, healthy elderly individuals, people with diagnosed cases of MCI, and a control group of age-matched individuals without MCI. The first three groups each had 100 members and the last two each had 50.

During the FCSRT, the researchers showed the participants descriptive words, such as "part of the body" and "artery" and asked the participants to choose the picture that fit these cues from a set of 24 images, in this case, a picture of a heart. The psychologists then asked the subjects to recall as many items as they could. For objects they failed to remember, the psychologists provided the category cues, providing more information and testing the limits of the subjects' capacity.
The researchers analyzed the response times for the tasks and the number of items that were recalled, with and without additional cues. The MCI group showed the greatest sensitivity to added cues -- the additional input either substantially helped or inhibited their performance. But like the computer model, estimates of capacity highlighted the greatest cognitive difference between the MCI group and the others.
This study's approach to defining processing capacity is unusual. The scientists combined disparate principles of engineering and statistics, mathematically translating processing capacity into what is called the "hazard function."

The hazard function is well known in engineering, but relatively new for fields like psychology. It gives the probability that a task that is not yet completed will be completed in the next interval of time.

By measuring how long it takes a participant to recall the objects during the FCSRT, the psychologists fit a model based on the hazard function to each participant and obtain a measure of his or her capacity for the memorization task.

The difference in hazard function measures between the MCI group and all other groups was statistically much more pronounced than the differences between all groups in the number of items they recalled. These hazard function differences also outweighed the contrasts between all groups in their response times. The hazard function model proved to be the most sensitive diagnostic for cognitive distinctions in the groups, making it a reliable indicator of capacity and a better signal of the underlying hippocampal atrophy than processing speed alone.

The researchers' results are valid for every person, not just for the whole group. Since the modified FCSRT relies on personal reaction times, hazard analysis and performance, it can track the progression of MCI for anyone, anywhere there is access to a computer.

"These results are still preliminary, but very encouraging," Wenger said. "We plan to study what this approach can tell us about mental impairments related to other conditions, like iron deficiencies, in the future."

Wenger worked with Selamawit Negash, neurology research fellow, Ronald C. Peterson, professor of neurology, and Lyndsay Peterson, research associate, all at the Mayo Clinic College of Medicine.

The National Institute on Aging provided funding for this project



Related Information:

  • The Washington Post report regarding our center and specialized stem cell treatment   
  • Stem cell therapy, a promising novel endeavor for neurological disorders   
  • Major ALS breakthrough-common cause of all forms of ALS discovered   
  • Imaging Study Shows Slower Growth In Autistic Brains Extending Into Adolescence   
  • 'Pushing Limits' - New Drug Strategies For Alzheimer's, Multiple Sclerosis   
  • Study Suggests Varying Practice Sessions May Benefit People With Motor Disorders   
  • New Drug Strategies for Alzheimer's and Multiple Sclerosis   
  • Antiviral Drugs May Slow Alzheimer's Progression   
  • Precision With Stem Cells a Step Forward for Treating Multiple Sclerosis, Other Diseases   
  • Minority Children Less Likely to Receive CT Scans Following Head Trauma   
  • Reassurance for Dementia Sufferers On Impact of Common Drugs   
  • Understanding the Beginnings of Embryonic Stem Cells Helps Predict the Future   
  • By Reprogramming Skin Cells Into Brain Cells, Scientists Gain New Insights Into Mental Disorders   
  • Family History May Have More Important Role Than Previously Thought in Development of Alzheimer Disease   
  • Evidence Points to Potential Roles for Cognitive Rehabilitation Therapy in Treating Traumatic Brain Injury,   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • New Drug Target for Alzheimer's, Stroke Discovered   
  • A Safe Vaccination for Alzheimer's Disease?   
  • Think You're in Poor Health? It Could Increase Your Odds of Dementia   
  • Models of Autism Show That Gene Copy Number Controls Brain Structure and Behavior   
  • Patient-Specific Stem Cells: Major Step Toward Cell-Based Therapies for Life-Threatening Diseases   
  • One Quarter of Seniors Over 70 Have Had Silent Strokes   
  • Remitting Multiple Sclerosis: Natalizumab Reduces Relapses and Disability   
  • Seeds of Destruction in Parkinson's Disease: Spread of Diseased Proteins Kills Neurons   
  • Even High-But-Normal Blood Pressure Elevates Stroke Risk   
  • Commonly Used Supplement May Improve Recovery from Spinal Cord Injuries   
  • Key to Survival of Brain Cells Discovered   
  • Correcting Sickle Cell Disease With Stem Cells   
  • New Stem Cell Activity Identified in Human Brain   
  • New Stem Cell Activity Identified in Human Brain   
  • Treatment
    The Parkinson's Clinical Center
    Doctor Blogs
    Treatment Data
    Contact Us

  • What are stem cells and how do they work to treat various diseases?   
  • How do stem cells know where to go and what to do?   
  • What kinds of stem cells does your medical center use and are they safe?   
  • Where do the stem cells come from?   
  • Is stem cell treatment safe? Is it really effective?   
  • How do I know if I am a good candidate for stem cell therapy?   
  • How long should I expect to stay in Beijing for the treatment?   
  • Can you use adult stem cells from my own bone marrow?   
  • What methods do you use to transplant stem cells into the patient's body?   
  • What should I expect to experience during the stem cell treatment?   
  • Do the doctors use anesthesia during the operation?   
  • What other drugs does the doctor combine with the stem cells for therapy?   
  • How long after surgery will it be before I can bathe or shower?   
  • For Batten disease treatment, what type of stem cells are used?   
  • About the neural growth factors that your medical center use   
  • If your hospitals have an age restriction on patients?   
  • What medications do you use on Batten disease patients?   
  • Is it possible for you to manufacture the TPP1 enzyme and deliver it?   
  • When I send my records to your hospital, does a doctor read them?   
  • Is general anesthesia used?   
  • Is other therapy done in addition to stem cell infusion?   
  • What types of rehabilitation training is done?   
  • What will my treatment schedule be like?   
  • Does the doctor have to penetrate the spinal canal to infuse the stem cells   
  • If I have to have surgery, how long will it take for the wound to heal?   
  • Will I lose very much blood?   
  • If there is surgery, can I fly back home before the wound has healed?   
  • Does your medical center also offer conventional treatment?   
  • What is the most effective way to contact us?   
  • Are stem cells pre-tested for HIV and Hepatitis? What else do you test?   
  • Send Inquiry Contact Us Sitemap Help

    Link:Like Cell Research Center | stemcellshezhong.com
    Copyright © 2011 unistemcells.com All rights reserved.